See today's BioWorld MedTech
To read the full story, subscribe or sign in.

Tempus Labs wins reversal of patent rejection over machine learning

Nov. 12, 2024
By Mark McCarty
Abstract ideas are not generally eligible for patents in the U.S., but a recent dispute heard by the U.S. Patent Trial and Appeal Board adds a new twist to the question.
BioWorld MedTech Regulatory Artificial intelligence U.S. Patents